Next-Generation Breast Cancer Diagnostic and Screening and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Next-Generation Breast Cancer Diagnostic and Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next-Generation Breast Cancer Diagnostic and Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next-Generation Breast Cancer Diagnostic and Screening Overall Market Size
2.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size: 2021 VS 2028
2.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next-Generation Breast Cancer Diagnostic and Screening Players in Global Market
3.2 Top Global Next-Generation Breast Cancer Diagnostic and Screening Companies Ranked by Revenue
3.3 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Companies
3.4 Top 3 and Top 5 Next-Generation Breast Cancer Diagnostic and Screening Companies in Global Market, by Revenue in 2021
3.5 Global Companies Next-Generation Breast Cancer Diagnostic and Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next-Generation Breast Cancer Diagnostic and Screening Players in Global Market
3.6.1 List of Global Tier 1 Next-Generation Breast Cancer Diagnostic and Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Next-Generation Breast Cancer Diagnostic and Screening Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Markets, 2021 & 2028
4.1.2 Real-Time PCR (q-PCR)
4.1.3 Immunohistochemistry (IHC)
4.1.4 Next-Generation Sequencing (NGS)
4.1.5 Fluorescent In-Situ Hybridization (FISH)
4.2 By Type - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue & Forecasts
4.2.1 By Type - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2017-2022
4.2.2 By Type - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2023-2028
4.2.3 By Type - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2021 & 2028
5.1.2 Hospital-associated Labs
5.1.3 Cancer Research Institutes
5.1.4 Diagnostic Centers
5.2 By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue & Forecasts
5.2.1 By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2017-2022
5.2.2 By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2023-2028
5.2.3 By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2021 & 2028
6.2 By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue & Forecasts
6.2.1 By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2017-2022
6.2.2 By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2023-2028
6.2.3 By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2017-2028
6.3.2 US Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.3.3 Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.3.4 Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2017-2028
6.4.2 Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.4.3 France Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.4.4 U.K. Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.4.5 Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.4.6 Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.4.7 Nordic Countries Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.4.8 Benelux Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2017-2028
6.5.2 China Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.5.3 Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.5.4 South Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.5.5 Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.5.6 India Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2017-2028
6.6.2 Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.6.3 Argentina Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2017-2028
6.7.2 Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.7.3 Israel Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.7.4 Saudi Arabia Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
6.7.5 UAE Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.1.4 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Agendia
7.2.1 Agendia Corporate Summary
7.2.2 Agendia Business Overview
7.2.3 Agendia Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.2.4 Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.2.5 Agendia Key News
7.3 Agilent Technologies
7.3.1 Agilent Technologies Corporate Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.3.4 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.3.5 Agilent Technologies Key News
7.4 Ambry Genetics
7.4.1 Ambry Genetics Corporate Summary
7.4.2 Ambry Genetics Business Overview
7.4.3 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.4.4 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.4.5 Ambry Genetics Key News
7.5 Biocept
7.5.1 Biocept Corporate Summary
7.5.2 Biocept Business Overview
7.5.3 Biocept Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.5.4 Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.5.5 Biocept Key News
7.6 Biotheranostics
7.6.1 Biotheranostics Corporate Summary
7.6.2 Biotheranostics Business Overview
7.6.3 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.6.4 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.6.5 Biotheranostics Key News
7.7 Centogene
7.7.1 Centogene Corporate Summary
7.7.2 Centogene Business Overview
7.7.3 Centogene Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.7.4 Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.7.5 Centogene Key News
7.8 Danaher Corporation
7.8.1 Danaher Corporation Corporate Summary
7.8.2 Danaher Corporation Business Overview
7.8.3 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.8.4 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.8.5 Danaher Corporation Key News
7.9 EXACT Sciences Corporation
7.9.1 EXACT Sciences Corporation Corporate Summary
7.9.2 EXACT Sciences Corporation Business Overview
7.9.3 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.9.4 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.9.5 EXACT Sciences Corporation Key News
7.10 Roche Holding AG
7.10.1 Roche Holding AG Corporate Summary
7.10.2 Roche Holding AG Business Overview
7.10.3 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.10.4 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.10.5 Roche Holding AG Key News
7.11 Fulgent Genetics
7.11.1 Fulgent Genetics Corporate Summary
7.11.2 Fulgent Genetics Business Overview
7.11.3 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.11.4 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.11.5 Fulgent Genetics Key News
7.12 Illumina
7.12.1 Illumina Corporate Summary
7.12.2 Illumina Business Overview
7.12.3 Illumina Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.12.4 Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.12.5 Illumina Key News
7.13 Invitae
7.13.1 Invitae Corporate Summary
7.13.2 Invitae Business Overview
7.13.3 Invitae Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.13.4 Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.13.5 Invitae Key News
7.14 Lucence Diagnostics Pte Ltd
7.14.1 Lucence Diagnostics Pte Ltd Corporate Summary
7.14.2 Lucence Diagnostics Pte Ltd Business Overview
7.14.3 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.14.4 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.14.5 Lucence Diagnostics Pte Ltd Key News
7.15 Myriad Genetics
7.15.1 Myriad Genetics Corporate Summary
7.15.2 Myriad Genetics Business Overview
7.15.3 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.15.4 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2017-2022)
7.15.5 Myriad Genetics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Next-Generation Breast Cancer Diagnostic and Screening Market Opportunities & Trends in Global Market
Table 2. Next-Generation Breast Cancer Diagnostic and Screening Market Drivers in Global Market
Table 3. Next-Generation Breast Cancer Diagnostic and Screening Market Restraints in Global Market
Table 4. Key Players of Next-Generation Breast Cancer Diagnostic and Screening in Global Market
Table 5. Top Next-Generation Breast Cancer Diagnostic and Screening Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Share by Companies, 2017-2022
Table 8. Global Companies Next-Generation Breast Cancer Diagnostic and Screening Product Type
Table 9. List of Global Tier 1 Next-Generation Breast Cancer Diagnostic and Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Next-Generation Breast Cancer Diagnostic and Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 32. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 33. Agendia Corporate Summary
Table 34. Agendia Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 35. Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 36. Agilent Technologies Corporate Summary
Table 37. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 38. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 39. Ambry Genetics Corporate Summary
Table 40. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 41. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 42. Biocept Corporate Summary
Table 43. Biocept Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 44. Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 45. Biotheranostics Corporate Summary
Table 46. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 47. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 48. Centogene Corporate Summary
Table 49. Centogene Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 50. Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 51. Danaher Corporation Corporate Summary
Table 52. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 53. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 54. EXACT Sciences Corporation Corporate Summary
Table 55. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 56. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 57. Roche Holding AG Corporate Summary
Table 58. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 59. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 60. Fulgent Genetics Corporate Summary
Table 61. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 62. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 63. Illumina Corporate Summary
Table 64. Illumina Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 65. Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 66. Invitae Corporate Summary
Table 67. Invitae Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 68. Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 69. Lucence Diagnostics Pte Ltd Corporate Summary
Table 70. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 71. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
Table 72. Myriad Genetics Corporate Summary
Table 73. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offerings
Table 74. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Next-Generation Breast Cancer Diagnostic and Screening Segment by Type in 2021
Figure 2. Next-Generation Breast Cancer Diagnostic and Screening Segment by Application in 2021
Figure 3. Global Next-Generation Breast Cancer Diagnostic and Screening Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Next-Generation Breast Cancer Diagnostic and Screening Revenue in 2021
Figure 8. By Type - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
Figure 9. By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
Figure 10. By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
Figure 11. By Country - North America Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
Figure 12. US Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
Figure 16. Germany Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 17. France Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
Figure 24. China Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 28. India Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
Figure 30. Brazil Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2017-2028
Figure 33. Turkey Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Next-Generation Breast Cancer Diagnostic and Screening Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
